Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | $11.60B | $3.70B | $919.43M | $597.60M | $2.67 | 8.87% | 14.45% | 74.51% | 38.71% | 2024-06-13 | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.66B | $582.02M | $221.51M | $128.85M | $2.17 | 32.93% | N/A | -29.32% | N/A | 2024-05-29 | |
| VYGR | VOYAGER THERAPEUTICS INC | $413.77M | $250.01M | $126.46M | $132.33M | $3.08 | 511.16% | 101.01% | N/A | N/A | 2024-06-05 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $119.30M | $380.79M | $55.39M | $49.27M | $0.73 | 1,612.94% | N/A | N/A | N/A | 2024-06-06 | |
| UTHR | UNITED THERAPEUTICS CORP | $11.00B | $2.33B | $1.39B | $984.80M | $21.04 | 20.20% | 7.41% | 31.66% | 9.22% | 2024-06-25 | |
| CORT | CORCEPT THERAPEUTICS INC | $2.36B | $482.38M | $109.00M | $105.50M | $1.02 | 20.04% | 13.93% | 7.37% | 9.43% | 2024-05-17 | |
| EXEL | EXELIXIS INC | $7.19B | $1.83B | $312.21M | $207.77M | $0.65 | 13.60% | 16.47% | 14.04% | -22.47% | 2024-05-30 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.36B | $2.47B | $359.85M | $205.46M | $1.09 | 13.74% | 10.23% | 194.59% | N/A | 2024-05-21 | |
| PBYI | PUMA BIOTECHNOLOGY INC | $242.00M | $235.64M | $47.52M | $21.59M | $0.46 | 3.34% | -1.25% | N/A | N/A | 2024-06-12 | |
| HALO | HALOZYME THERAPEUTICS INC | $4.89B | $829.25M | $451.95M | $281.59M | $2.13 | 25.62% | 40.43% | 43.92% | N/A | 2024-05-07 | |
| RPRX | ROYALTY PHARMA PLC | $16.73B | $2.35B | $1.32B | $1.13B | $2.54 | 5.24% | 5.58% | 2,440.00% | N/A | 2024-06-21 | |
| TGTX | TG THERAPEUTICS INC | $2.08B | $233.66M | $25.89M | $12.67M | $0.09 | 8,290.02% | 333.86% | N/A | N/A | 2024-06-14 | |
| ROIV | ROIVANT SCIENCES LTD | $8.89B | $123.24M | $4.58B | $4.47B | $5.56 | 185.76% | N/A | N/A | N/A | 2024-06-26 | |
| GMAB | GENMAB A | $18.60B | $2.40B | N/A | $633.48M | $0.97 | 16.77% | 39.38% | -17.74% | 21.77% | 2024-05-02 | |
| MEIP | MEI PHARMA INC | $20.32M | $72.65M | $21.69M | $19.84M | $2.97 | 16.10% | 83.24% | N/A | N/A | 2024-05-09 | |
| MDXG | MIMEDX GROUP INC | $921.43M | $321.48M | $32.57M | $58.23M | $0.40 | 20.03% | -2.19% | N/A | N/A | 2024-06-05 | |
| BNTX | BIONTECH SE | $20.73B | $4.15B | $1.51B | $1.01B | $4.21 | -76.96% | 96.02% | -89.58% | N/A | 2024-05-17 | |
| REGN | REGENERON PHARMACEUTICALS INC | $96.94B | $13.12B | $4.69B | $3.95B | $37.05 | 7.76% | 20.58% | -8.54% | 10.34% | 2024-06-14 | |
| VNDA | VANDA PHARMACEUTICALS INC | $265.82M | $192.64M | $9.35M | $2.51M | $0.04 | -24.27% | -0.05% | -63.64% | -39.66% | 2024-06-07 | |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $84.01M | $65.49M | $11.65M | $8.31M | $0.12 | 37.48% | 13.85% | N/A | N/A | 2024-06-27 | |
| DBVT | DBV TECHNOLOGIES SA | $131.53M | $15.73M | -$86.72M | -$72.73M | -$0.38 | 224.69% | -0.69% | N/A | N/A | 2024-05-02 | |
| SPRO | SPERO THERAPEUTICS INC | $78.65M | $103.78M | $25.77M | $22.81M | $0.43 | 93.95% | 92.11% | N/A | N/A | 2024-05-09 | |
| AVRO | AVROBIO INC | $54.28M | $0.00 | $12.64M | $12.16M | $0.27 | N/A | N/A | N/A | N/A | 2024-06-05 | |
| BNOX | BIONOMICS LIMITED | $11.55M | $14.50k | N/A | -$20.40M | $32.92 | -91.52% | N/A | 261.25% | N/A | 2024-04-29 | |
| CPRX | CATALYST PHARMACEUTICALS INC | $1.75B | $398.20M | $127.65M | $71.41M | $0.67 | 85.90% | 280.39% | -16.25% | N/A | 2024-05-30 | |
| CRSP | CRISPR THERAPEUTICS AG | $4.33B | $371.21M | -$130.89M | -$153.61M | -$1.94 | 30,885.48% | 160.00% | N/A | N/A | 2024-05-30 | |
| KRYS | KRYSTAL BIOTECH INC | $4.44B | $50.70M | $17.90M | $10.93M | $0.40 | N/A | N/A | N/A | N/A | 2024-05-17 | |
| VRTX | VERTEX PHARMACEUTICALS INC | $102.67B | $9.87B | $4.61B | $3.62B | $14.05 | 10.51% | 26.49% | 8.33% | 11.26% | 2024-05-15 | |
| OCUP | OCUPHIRE PHARMA INC | $39.95M | $19.05M | -$9.97M | -$9.99M | -$0.46 | -52.20% | N/A | N/A | N/A | 2024-06-11 | |
| TFFP | TFF PHARMACEUTICALS INC | $7.36M | $733.87k | -$20.74M | -$21.24M | -$11.85 | 48.02% | N/A | N/A | N/A | 2024-06-04 | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $1.27B | $301.77M | -$16.36M | $8.65M | $0.12 | 27.69% | N/A | -95.74% | N/A | 2024-06-05 | |
| SEER | SEER INC | $123.72M | $16.66M | -$80.49M | -$86.28M | -$1.35 | 7.54% | N/A | N/A | N/A | 2024-06-13 | |
| MIRM | MIRUM PHARMACEUTICALS INC | $1.15B | $186.37M | -$135.87M | -$163.42M | -$4.00 | 141.85% | N/A | N/A | N/A | 2024-06-05 | |
| NVO | NOVO NORDISK A S | $572.09B | $33.81B | $16.66B | $12.18B | $2.72 | 34.95% | 14.94% | 56.54% | 17.71% | 2024-05-02 | |
| ADAG | ADAGENE INC | $105.44M | $18.11M | -$14.94M | -$18.95M | -$0.44 | 94.90% | 64.33% | N/A | N/A | ||
| IMMP | IMMUTEP LTD | $315.04M | $4.40M | N/A | -$26.47M | -$0.26 | 5.09% | 4.12% | N/A | N/A | ||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $1.12B | $91.37M | -$152.07M | -$147.03M | -$2.76 | 69.50% | 148.98% | N/A | N/A | 2024-05-14 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.82B | $3.83B | $1.22B | $414.83M | $6.55 | 4.78% | 15.19% | N/A | -2.54% | 2024-05-01 | |
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $67.46M | $10.96M | -$6.41M | -$7.02M | -$0.62 | 3,565.22% | 16.93% | N/A | N/A | 2024-05-22 | |
| IDYA | IDEAYA BIOSCIENCES INC | $2.98B | $23.39M | -$108.95M | -$112.96M | -$1.96 | -54.08% | N/A | N/A | N/A | 2024-05-31 | |
| AGIO | AGIOS PHARMACEUTICALS INC | $1.77B | $26.82M | -$334.75M | -$352.09M | -$6.33 | 88.36% | -22.25% | N/A | N/A | 2024-05-02 | |
| VTGN | VISTAGEN THERAPEUTICS INC | $128.37M | $1.04M | -$31.51M | -$32.07M | -$3.43 | N/A | N/A | N/A | N/A | 2024-06-26 | |
| RNA | AVIDITY BIOSCIENCES INC | $1.94B | $9.56M | -$207.14M | -$212.22M | -$2.91 | 3.64% | 90.71% | N/A | N/A | 2024-05-07 | |
| VYNE | VYNE THERAPEUTICS INC | $35.25M | $424.00k | -$28.45M | -$28.45M | -$2.78 | -11.11% | -34.79% | N/A | N/A | 2024-05-09 | |
| MDWD | MEDIWOUND LTD | $168.20M | $18.69M | -$3.34M | -$6.72M | -$0.75 | -29.48% | 40.60% | N/A | N/A | 2024-05-30 | |
| LPCN | LIPOCINE INC | $25.51M | -$2.85M | -$16.32M | -$16.35M | -$3.10 | N/A | N/A | N/A | N/A | 2024-06-05 | |
| ORMP | ORAMED PHARMACEUTICALS INC | $99.68M | $1.34M | $7.76M | $5.53M | $0.14 | -50.43% | -13.14% | N/A | N/A | 2024-05-09 | |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $714.60M | $166.80M | -$41.52M | -$29.73M | -$1.12 | -19.03% | 60.31% | N/A | N/A | 2024-06-13 | |
| ALGS | ALIGOS THERAPEUTICS INC | $59.17M | $15.53M | -$85.06M | -$87.68M | -$1.36 | 11.66% | N/A | N/A | N/A | 2024-06-27 | |
| KZR | KEZAR LIFE SCIENCES INC | $58.61M | $7.00M | -$99.25M | -$101.87M | -$1.40 | N/A | N/A | N/A | N/A | 2024-06-18 | |
| INM | INMED PHARMACEUTICALS INC | $1.39M | $5.49M | -$5.75M | -$6.35M | -$1.27 | 239.77% | N/A | N/A | N/A | 2024-05-13 | |
| GNFT | GENFIT SA | $173.92M | $41.50M | -$23.09M | -$31.41M | -$0.63 | 50.09% | 37.55% | N/A | N/A | ||
| EDIT | EDITAS MEDICINE INC | $435.25M | $78.12M | -$164.72M | -$153.22M | -$2.02 | 296.32% | 19.59% | N/A | N/A | 2024-05-31 | |
| AXSM | AXSOME THERAPEUTICS INC | $3.40B | $270.60M | -$223.54M | -$239.24M | -$5.27 | 440.80% | N/A | N/A | N/A | 2024-06-07 | |
| XCUR | EXICURE INC | $4.32M | $23.79M | $5.04M | $3.07M | $1.68 | 584.21% | 38.63% | N/A | -72.96% | ||
| FULC | FULCRUM THERAPEUTICS INC | $442.22M | $2.81M | -$95.16M | -$97.34M | -$1.59 | -55.77% | N/A | N/A | N/A | 2024-06-17 | |
| ANIX | ANIXA BIOSCIENCES INC | $103.04M | $210.00k | -$10.70M | -$10.74M | -$0.34 | N/A | -28.36% | N/A | N/A | 2024-06-07 | |
| LIFE | ATYR PHARMA INC | $106.37M | $353.00k | -$47.65M | -$50.39M | -$0.94 | -96.60% | N/A | N/A | N/A | 2024-05-22 | |
| GLPG | GALAPAGOS NV | $1.90B | $260.57M | $240.55M | $230.11M | $3.49 | 3.78% | -5.51% | N/A | N/A | 2024-05-02 | |
| TECH | BIO-TECHNE CORP | $10.07B | $1.14B | $372.91M | $224.16M | $1.41 | 2.25% | 10.93% | -15.57% | 17.11% | 2024-05-01 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | $1.47B | $60.00M | -$75.64M | -$78.96M | -$1.39 | 125.73% | 14.17% | N/A | N/A | 2024-06-20 | |
| LEGN | LEGEND BIOTECH CORP | $8.24B | $285.14M | -$477.87M | -$518.25M | -$2.94 | 143.70% | 42.15% | N/A | N/A | 2024-05-13 | |
| ZLAB | ZAI LAB LTD | $1.58B | $266.72M | -$316.88M | -$334.62M | -$3.50 | 24.03% | 360.35% | N/A | N/A | 2024-05-07 | |
| XBIO | XENETIC BIOSCIENCES INC | $6.30M | $2.54M | -$4.13M | -$4.13M | -$2.71 | 48.80% | N/A | N/A | N/A | 2024-05-09 | |
| MRUS | MERUS NV | $2.61B | $43.95M | -$163.72M | -$154.94M | -$3.00 | 5.68% | 2.75% | N/A | N/A | 2024-05-07 | |
| NRBO | NEUROBO PHARMACEUTICALS INC | $15.40M | $0.00 | -$12.46M | -$12.47M | -$2.46 | N/A | N/A | N/A | N/A | 2024-06-27 | |
| ACIU | AC IMMUNE SA | $233.11M | $16.82M | -$58.90M | -$61.63M | -$0.73 | 316.44% | 20.10% | N/A | N/A | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $42.32M | $7.88M | -$64.39M | -$69.20M | -$1.83 | 37.48% | N/A | N/A | N/A | 2024-05-09 | |
| ARGX | ARGENX SE | $22.07B | $38.62M | -$209.00M | -$320.71M | -$5.61 | 270.16% | 9.84% | N/A | N/A | 2024-05-09 | |
| SLGL | SOL-GEL TECHNOLOGIES LTD | $24.79M | $1.55M | -$26.90M | -$27.24M | -$1.01 | -59.98% | 64.50% | N/A | N/A | 2024-05-10 | |
| FUSN | FUSION PHARMACEUTICALS INC | $1.81B | $2.07M | -$85.08M | -$94.90M | -$1.45 | 41.55% | N/A | N/A | N/A | 2024-06-13 | |
| FATE | FATE THERAPEUTICS INC | $377.10M | $63.53M | -$142.65M | -$160.93M | -$1.64 | -34.03% | 68.05% | N/A | N/A | 2024-05-01 | |
| BCYC | BICYCLE THERAPEUTICS PLC | $967.98M | $26.98M | -$169.40M | -$180.66M | -$5.08 | 86.52% | 30.47% | N/A | N/A | 2024-05-16 | |
| CLNN | CLENE INC | $43.67M | $654.00k | -$42.81M | -$49.50M | -$0.47 | 38.27% | N/A | N/A | N/A | 2024-05-29 | |
| ZVRA | ZEVRA THERAPEUTICS INC | $196.29M | $27.46M | -$43.54M | -$46.05M | -$1.30 | 170.26% | N/A | N/A | N/A | 2024-05-13 | |
| IGMS | IGM BIOSCIENCES INC | $552.59M | $2.13M | -$232.05M | -$246.42M | -$4.71 | 99.25% | N/A | N/A | N/A | 2024-06-11 | |
| TRAW | TRAWS PHARMA INC | $13.07M | $226.00k | -$18.93M | -$18.95M | -$0.90 | 0.00% | -28.72% | N/A | N/A | 2024-05-13 | |
| JANX | JANUX THERAPEUTICS INC | $2.45B | $8.08M | -$56.34M | -$58.29M | -$1.32 | -6.14% | N/A | N/A | N/A | 2024-05-10 | |
| MRKR | MARKER THERAPEUTICS INC | $38.19M | $3.31M | -$8.23M | -$8.24M | -$0.94 | -5.76% | 74.27% | N/A | N/A | 2024-06-05 | |
| VERV | VERVE THERAPEUTICS INC | $515.09M | $11.76M | -$187.55M | -$200.07M | -$3.12 | 505.77% | N/A | N/A | N/A | 2024-05-07 | |
| ALT | ALTIMMUNE INC | $514.70M | $426.00k | -$87.94M | -$88.45M | -$1.66 | N/A | -47.15% | N/A | N/A | 2024-05-15 | |
| ZYME | ZYMEWORKS INC | $582.89M | $76.01M | -$101.94M | -$118.67M | -$1.72 | -81.57% | 7.47% | N/A | N/A | ||
| RYTM | RHYTHM PHARMACEUTICALS INC | $2.30B | $77.43M | -$168.46M | -$184.68M | -$3.20 | 227.56% | N/A | N/A | N/A | 2024-06-20 | |
| PLRX | PLIANT THERAPEUTICS INC | $711.42M | $1.58M | -$155.84M | -$161.34M | -$2.75 | -83.69% | N/A | N/A | N/A | 2024-06-13 | |
| SPRB | SPRUCE BIOSCIENCES INC | $28.80M | $10.09M | -$47.14M | -$47.92M | -$1.24 | N/A | N/A | N/A | N/A | 2024-05-22 | |
| ARDX | ARDELYX INC | $1.49B | $124.46M | -$55.65M | -$66.07M | -$0.30 | 138.61% | 116.66% | N/A | N/A | 2024-06-14 | |
| BGNE | BEIGENE LTD | $16.08B | $2.46B | -$812.17M | -$881.71M | -$0.65 | 73.65% | 65.47% | N/A | N/A | 2024-05-02 | |
| CALT | CALLIDITAS THERAPEUTICS AB | $580.94M | $110.93M | -$31.50M | -$42.85M | -$1.60 | 55.09% | N/A | N/A | N/A | 2024-05-07 | |
| CDIO | CARDIO DIAGNOSTICS HOLDINGS INC | $14.90M | $17.07k | -$1.53M | -$8.38M | -$0.66 | 1,696.32% | N/A | N/A | N/A | ||
| ITOS | ITEOS THERAPEUTICS INC | $387.11M | $12.60M | -$108.13M | -$112.64M | -$3.15 | -95.29% | N/A | N/A | N/A | 2024-06-11 | |
| SPRY | ARS PHARMACEUTICALS INC | $805.79M | $30.00k | -$54.29M | -$54.37M | -$0.57 | -97.72% | N/A | N/A | N/A | 2024-06-26 | |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | $97.30M | $802.00k | -$69.64M | -$73.35M | -$1.91 | -98.21% | N/A | N/A | N/A | 2024-05-10 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $834.67M | $46.02M | -$69.00M | -$70.80M | -$1.82 | 11.14% | 58.70% | N/A | N/A | 2024-06-19 | |
| RVMD | REVOLUTION MEDICINES INC | $5.92B | $11.58M | -$430.28M | -$436.37M | -$3.86 | -67.27% | -10.50% | N/A | N/A | 2024-06-07 | |
| IMCR | IMMUNOCORE HOLDINGS PLC | $2.91B | $249.43M | -$50.00M | -$55.29M | -$1.13 | 43.05% | 53.19% | N/A | N/A | 2024-05-31 | |
| STTK | SHATTUCK LABS INC | $502.76M | $1.66M | -$82.89M | -$87.30M | -$2.05 | 154.14% | -40.62% | N/A | N/A | 2024-06-07 | |
| IFRX | INFLARX NV | $78.31M | $68.58k | -$45.72M | -$46.38M | -$0.85 | N/A | N/A | N/A | N/A | 2024-05-09 | |
| SAGE | SAGE THERAPEUTICS INC | $823.89M | $91.06M | -$501.74M | -$503.14M | -$8.39 | 868.87% | 0.07% | N/A | N/A | 2024-06-10 | |
| CVAC | CUREVAC NV | $521.89M | $57.80M | -$251.71M | -$279.75M | -$1.27 | -16.72% | 32.20% | N/A | N/A | 2024-06-18 | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $2.93B | $4.01M | -$212.22M | -$214.53M | -$3.69 | -15.28% | 10.57% | N/A | N/A | 2024-06-14 |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.